Related Experiment Video
Updated: Sep 29, 2025

Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue
Published on: May 17, 2018
Functional Decline in the Cancer Patient: A Review
Jaidyn Muhandiramge1, Suzanne G Orchard1, Erica T Warner2
1Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia.
Older cancer patients experience accelerated functional decline, impacting quality of life. Routine assessments and interventions can slow this decline, improving outcomes for cancer survivors.
Area of Science:
- Gerontology
- Oncology
- Rehabilitation Medicine
Background:
- Functional status decline is a normal part of aging.
- Older cancer patients experience accelerated functional decline due to cancer and its treatments.
- This decline is linked to reduced quality of life, increased mortality, and dependency.
Purpose of the Study:
- To review the relationship between cancer and functional decline in older adults.
- To explore underlying mechanisms and assessment tools for functional status.
- To outline strategies for prevention and management of functional decline in this population.
Main Methods:
- Literature review of studies on aging, cancer, and functional status.
- Analysis of mechanisms linking cancer/treatment to functional decline.
- Identification and evaluation of assessment tools and intervention strategies.
Main Results:
- Cancer and its treatments significantly accelerate functional decline in older patients.
- Functional decline is associated with adverse health outcomes.
- Current long-term care for cancer survivors often lacks routine functional status assessment and intervention.
Conclusions:
- Routine assessment of functional status is crucial for older cancer patients.
- Timely interventions can mitigate or slow accelerated functional decline.
- Integrating functional status management into survivorship care is essential for improving long-term outcomes.
Related Concept Videos
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistant Cancers
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

